Bacopa monnieri for Managing and Treating Dementia

View at publisher Summarise with VIRAT
Authors: Gideon Opeyemi Ayilara, Patrick Oluwole Abolarin, Abosede Oreoluwa Bolaji, Oluwafemi Abiola Onaolapo, Olutayo Folajimi Olaseinde
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Dementia is a progressive neurodegenerative disorder associated with significant cognitive decline and memory impairment which ultimately reduce the quality of life. With limited therapeutic options, herbal medicine is gaining significant attention in the management of this neurological disorder. Bacopa monnieri ( BM ) is an Ayurvedic medicinal plant that has garnered increasing attention for its neuroprotective effect and cognitive-enhancing property. This chapter explores the phytochemical composition responsible for the mechanisms of action of BM in dementia management. It presents the clinical and preclinical evidence supporting the effectiveness of BM in dementia management. Preclinical evidence reveals that its key bioactive compounds like alkaloids, bacosides, flavonoids, and cucurbitacins exert multiple neuroprotective effects such as inhibition of amyloid-β and tau pathology, cholinergic modulation, and neurogenesis, among other actions explored in this chapter. Clinical evidence reveals that the plant shows improvements in memory, attention, and cognitive performance in patients suffering from mild cognitive impairment or dementia. Importantly, BM is generally safe and well-tolerated with only mild gastrointestinal disturbances reported in clinical studies.

Fields of Study & Subjects

Medicinal Plants and Neuroprotection Alzheimer's disease research and treatments Phytochemicals and Medicinal Plants

Publication details

Journal / source
CRC Press eBooks
Pages
40–47
Publication date
31 March 2026
Language
EN
Document type
Book chapter